231 related articles for article (PubMed ID: 22308955)
1. The role of transient receptor potential channel blockers in human gastric cancer cell viability.
Kim BJ; Kim SY; Lee S; Jeon JH; Matsui H; Kwon YK; Kim SJ; So I
Can J Physiol Pharmacol; 2012 Feb; 90(2):175-86. PubMed ID: 22308955
[TBL] [Abstract][Full Text] [Related]
2. Suppression of transient receptor potential melastatin 7 channel induces cell death in gastric cancer.
Kim BJ; Park EJ; Lee JH; Jeon JH; Kim SJ; So I
Cancer Sci; 2008 Dec; 99(12):2502-9. PubMed ID: 19032368
[TBL] [Abstract][Full Text] [Related]
3. Blockade of TRPM7 channel activity and cell death by inhibitors of 5-lipoxygenase.
Chen HC; Xie J; Zhang Z; Su LT; Yue L; Runnels LW
PLoS One; 2010 Jun; 5(6):e11161. PubMed ID: 20567598
[TBL] [Abstract][Full Text] [Related]
4. Transient receptor potential melastatin 7 channels are involved in ginsenoside Rg3-induced apoptosis in gastric cancer cells.
Kim BJ; Nah SY; Jeon JH; So I; Kim SJ
Basic Clin Pharmacol Toxicol; 2011 Oct; 109(4):233-9. PubMed ID: 21443732
[TBL] [Abstract][Full Text] [Related]
5. Effects of transient receptor potential channel blockers on pacemaker activity in interstitial cells of Cajal from mouse small intestine.
Kim BJ; Nam JH; Kim SJ
Mol Cells; 2011 Aug; 32(2):153-60. PubMed ID: 21607648
[TBL] [Abstract][Full Text] [Related]
6. The role of waixenicin A as transient receptor potential melastatin 7 blocker.
Kim BJ; Nam JH; Kwon YK; So I; Kim SJ
Basic Clin Pharmacol Toxicol; 2013 Feb; 112(2):83-9. PubMed ID: 22901271
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic role and therapeutic target of transient receptor potential melastatin 7 channel in malignancy.
Zhou W; Guo S; Xiong Z; Liu M
Expert Opin Ther Targets; 2014 Oct; 18(10):1177-96. PubMed ID: 25069584
[TBL] [Abstract][Full Text] [Related]
8. Natural and synthetic modulators of SK (K(ca)2) potassium channels inhibit magnesium-dependent activity of the kinase-coupled cation channel TRPM7.
Chubanov V; Mederos y Schnitzler M; Meißner M; Schäfer S; Abstiens K; Hofmann T; Gudermann T
Br J Pharmacol; 2012 Jun; 166(4):1357-76. PubMed ID: 22242975
[TBL] [Abstract][Full Text] [Related]
9. TRPM2 channel-mediated regulation of autophagy maintains mitochondrial function and promotes gastric cancer cell survival via the JNK-signaling pathway.
Almasi S; Kennedy BE; El-Aghil M; Sterea AM; Gujar S; Partida-Sánchez S; El Hiani Y
J Biol Chem; 2018 Mar; 293(10):3637-3650. PubMed ID: 29343514
[TBL] [Abstract][Full Text] [Related]
10. Quercetin induces apoptosis by inhibiting MAPKs and TRPM7 channels in AGS cells.
Kim MC; Lee HJ; Lim B; Ha KT; Kim SY; So I; Kim BJ
Int J Mol Med; 2014 Jun; 33(6):1657-63. PubMed ID: 24647664
[TBL] [Abstract][Full Text] [Related]
11. Waixenicin A inhibits cell proliferation through magnesium-dependent block of transient receptor potential melastatin 7 (TRPM7) channels.
Zierler S; Yao G; Zhang Z; Kuo WC; Pörzgen P; Penner R; Horgen FD; Fleig A
J Biol Chem; 2011 Nov; 286(45):39328-35. PubMed ID: 21926172
[TBL] [Abstract][Full Text] [Related]
12. Mibefradil represents a new class of benzimidazole TRPM7 channel agonists.
Schäfer S; Ferioli S; Hofmann T; Zierler S; Gudermann T; Chubanov V
Pflugers Arch; 2016 Apr; 468(4):623-34. PubMed ID: 26669310
[TBL] [Abstract][Full Text] [Related]
13. Tissue-specific expression of TRP channel genes in the mouse and its variation in three different mouse strains.
Kunert-Keil C; Bisping F; Krüger J; Brinkmeier H
BMC Genomics; 2006 Jun; 7():159. PubMed ID: 16787531
[TBL] [Abstract][Full Text] [Related]
14. Suppression of TRPM7 enhances TRAIL-induced apoptosis in triple-negative breast cancer cells.
Song C; Choi S; Oh KB; Sim T
J Cell Physiol; 2020 Dec; 235(12):10037-10050. PubMed ID: 32468675
[TBL] [Abstract][Full Text] [Related]
15. Identification of TG100-115 as a new and potent TRPM7 kinase inhibitor, which suppresses breast cancer cell migration and invasion.
Song C; Bae Y; Jun J; Lee H; Kim ND; Lee KB; Hur W; Park JY; Sim T
Biochim Biophys Acta Gen Subj; 2017 Apr; 1861(4):947-957. PubMed ID: 28161478
[TBL] [Abstract][Full Text] [Related]
16. [Transient receptor potential melastatin 7 channel protein in human head and neck carcinoma cells and role in cell proliferation].
Jiang J; Lei WB; Shi JB; Su ZZ; Xiong ZG
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Jun; 43(6):451-5. PubMed ID: 18826101
[TBL] [Abstract][Full Text] [Related]
17. Function and regulation of the channel-kinase TRPM7 in health and disease.
Visser D; Middelbeek J; van Leeuwen FN; Jalink K
Eur J Cell Biol; 2014 Oct; 93(10-12):455-65. PubMed ID: 25073440
[TBL] [Abstract][Full Text] [Related]
18. Functional transient receptor potential melastatin 7 channels are critical for human mast cell survival.
Wykes RC; Lee M; Duffy SM; Yang W; Seward EP; Bradding P
J Immunol; 2007 Sep; 179(6):4045-52. PubMed ID: 17785843
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of TRPM7 suppresses cell proliferation of colon adenocarcinoma in vitro and induces hypomagnesemia in vivo without affecting azoxymethane-induced early colon cancer in mice.
Huang J; Furuya H; Faouzi M; Zhang Z; Monteilh-Zoller M; Kawabata KG; Horgen FD; Kawamori T; Penner R; Fleig A
Cell Commun Signal; 2017 Aug; 15(1):30. PubMed ID: 28810912
[TBL] [Abstract][Full Text] [Related]
20. 5-Lipoxygenase inhibitors attenuate growth of human renal cell carcinoma and induce apoptosis through arachidonic acid pathway.
Matsuyama M; Yoshimura R; Mitsuhashi M; Tsuchida K; Takemoto Y; Kawahito Y; Sano H; Nakatani T
Oncol Rep; 2005 Jul; 14(1):73-9. PubMed ID: 15944770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
